SCHEMBL20345906

SCHEMBL20345906

CC1(C)c2ccccc2-c2cc(N(c3ccc4c(c3)-c3ccccc3C4(c3ccccc3)c3ccccc3)c3ccc4c5ccccc5c5ccccc5c4c3)ccc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
OPRK1 P41145 1/20 0.39
KMT2A Q03164 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ESR1 P03372 1/20 0.34
ESR2 Q92731 1/20 0.34
MLNR O43193 1/20 0.30
NR1I2 O75469 1/20 0.30
CHRM2 P08172 1/20 0.30
ADRB1 P08588 1/20 0.30
HTR1A P08908 1/20 0.30
ADRA2A P08913 1/20 0.30
CHRM1 P11229 1/20 0.30
DRD2 P14416 1/20 0.30
ADRA2B P18089 1/20 0.30
ADRA2C P18825 1/20 0.30
CHRM3 P20309 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18468774 0.96 KDM4E (0.36) KDM4EMEN1LMNAMAPTOPRK1
SCHEMBL17854565 0.93 MEN1 (0.44) KDM4EMEN1LMNAMAPTOPRK1
SCHEMBL19218315 0.92 MLNR (0.33) KDM4EMEN1LMNAMAPTOPRK1
SCHEMBL19218336 0.92 MEN1 (0.42) KDM4EMEN1LMNAMAPTOPRK1
SCHEMBL18469174 0.92 MEN1 (0.45) KDM4EMEN1LMNAMAPTOPRK1
SCHEMBL17854472 0.92 MEN1 (0.45) KDM4EMEN1LMNAMAPTOPRK1
SCHEMBL21392534 0.91 KDM4E (0.35) KDM4EMEN1LMNAMAPTOPRK1
SCHEMBL17903150 0.91 MEN1 (0.45) KDM4EMEN1LMNAMAPTOPRK1
SCHEMBL20707410 0.91 KDM4E (0.41) KDM4EMEN1LMNAMAPTOPRK1
SCHEMBL20345912 0.91 KDM4E (0.34) KDM4EMEN1LMNAMAPTOPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10854822-B2 Compound, material for organic electroluminescent element, organic electroluminescent element, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2020-12-01 US disclosed
US-20180190904-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2018-07-05 US disclosed
US-20180190904-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2018-07-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180190904-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE ESR1, L1CAM, ELAVL1 KDM4E 864/4885MEN1 349/4885LMNA 527/4885
US-10854822-B2 Compound, material for organic electroluminescent element, organic electroluminescent element, and electronic device ESR1, L1CAM, ELAVL1 KDM4E 864/4885MEN1 349/4885LMNA 527/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.